Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 44
1997 39
1998 42
1999 32
2000 36
2001 41
2002 41
2003 45
2004 43
2005 41
2006 35
2007 34
2008 29
2009 41
2010 77
2011 85
2012 81
2013 93
2014 93
2015 102
2016 94
2017 85
2018 91
2019 88
2020 94
2021 74
2022 33
2023 27
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

1,335 results

Results by year

Filters applied: . Clear all
Page 1
Metabolic Syndrome.
Sherling DH, Perumareddi P, Hennekens CH. Sherling DH, et al. J Cardiovasc Pharmacol Ther. 2017 Jul;22(4):365-367. doi: 10.1177/1074248416686187. Epub 2017 Jan 9. J Cardiovasc Pharmacol Ther. 2017. PMID: 28587579 Review.
β-Blockers, Cocaine, and the Unopposed α-Stimulation Phenomenon.
Richards JR, Hollander JE, Ramoska EA, Fareed FN, Sand IC, Izquierdo Gómez MM, Lange RA. Richards JR, et al. J Cardiovasc Pharmacol Ther. 2017 May;22(3):239-249. doi: 10.1177/1074248416681644. Epub 2016 Dec 14. J Cardiovasc Pharmacol Ther. 2017. PMID: 28399647 Review.
Angina and Its Management.
Kloner RA, Chaitman B. Kloner RA, et al. J Cardiovasc Pharmacol Ther. 2017 May;22(3):199-209. doi: 10.1177/1074248416679733. Epub 2016 Dec 14. J Cardiovasc Pharmacol Ther. 2017. PMID: 28196437 Review.
A Comprehensive Review of PCSK9 Inhibitors.
Coppinger C, Movahed MR, Azemawah V, Peyton L, Gregory J, Hashemzadeh M. Coppinger C, et al. J Cardiovasc Pharmacol Ther. 2022 Jan-Dec;27:10742484221100107. doi: 10.1177/10742484221100107. J Cardiovasc Pharmacol Ther. 2022. PMID: 35593194 Free article. Review.
Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Diabetes and Non-Alcoholic Fatty Liver Disease-Current Evidence.
Muzurović EM, Volčanšek Š, Tomšić KZ, Janež A, Mikhailidis DP, Rizzo M, Mantzoros CS. Muzurović EM, et al. J Cardiovasc Pharmacol Ther. 2022 Jan-Dec;27:10742484221146371. doi: 10.1177/10742484221146371. J Cardiovasc Pharmacol Ther. 2022. PMID: 36546652 Free article. Review.
Age-Related Considerations in Cardio-Oncology.
Screever EM, Meijers WC, Moslehi JJ. Screever EM, et al. J Cardiovasc Pharmacol Ther. 2021 Mar;26(2):103-113. doi: 10.1177/1074248420968689. Epub 2020 Oct 30. J Cardiovasc Pharmacol Ther. 2021. PMID: 33124480 Review.
Angiotensin Receptor-Neprilysin Inhibition.
Havakuk O, Elkayam U. Havakuk O, et al. J Cardiovasc Pharmacol Ther. 2017 Jul;22(4):356-364. doi: 10.1177/1074248416683049. Epub 2016 Dec 28. J Cardiovasc Pharmacol Ther. 2017. PMID: 28587583 Review.
Epicardial Adipose Tissue and Diabetic Cardiomyopathy.
Yang X, Feng C, Feng J. Yang X, et al. J Cardiovasc Pharmacol Ther. 2023 Jan-Dec;28:10742484231151820. doi: 10.1177/10742484231151820. J Cardiovasc Pharmacol Ther. 2023. PMID: 36752345 Free article. Review.
Drug-Induced Takotsubo Cardiomyopathy.
Kido K, Guglin M. Kido K, et al. J Cardiovasc Pharmacol Ther. 2017 Nov;22(6):552-563. doi: 10.1177/1074248417708618. Epub 2017 May 11. J Cardiovasc Pharmacol Ther. 2017. PMID: 28490198 Review.
1,335 results